Most GHRP peptides (ghrelin agonists, GHRH analogs, BPC-157, TB-500, GHK copper peptide) lack FDA-approved indications and are used entirely off-label, so when off-label use occurs, clinicians should prioritize compounds with the lowest theoretical risk profiles and the longest histories of clinical use rather than novel compounds.

normativepending

Speaker

Dr. Kyle Gillette

Evidence Quote

“whenever there's not an approved indication and it hasn't been through all three stages of clinical trials and gotten approved then you want the theoretical risks to be as low as possible and you also want to be familiar with um how it's been used in the past”

Source

Complete Guide to Peptides for Fat Loss, Muscle Building & Longevity | Dr. Kyle Gillett MD— Thomas DeLauer
Created: 8/13/2026, 4:51:25 AM

Your notes

Loading notes...